Market Overview

Biodex and South West Exposures Announce Strategic Partnership Expanding Innovation with Global Outreach in Theranostics and Nuclear Medicine

Share:

Biodex Medical Systems, Inc. and SWE today announced a strategic partnership expanding the global theranostics and nuclear medicine offering in terms of availability and latest market innovation. A natural synergy combines SWE's new, highly efficient product design with the expansive network of global distributors and expertise of Biodex.

SHIRLEY, NY and TORONTO (PRWEB) October 13, 2019

The absolute revolution of nuclear medicine with the emergence of theranostics is forcing all stakeholders involved in the process to come up with new, outside-the-box thinking. Reducing exposure, ensuring safe manipulations, reducing weight, size and footprint for transportation while remaining efficient and ergonomically on point is no easy concept. SWE and Biodex joining forces provides innovative solutions that will address these paradigms increasing throughput, saving cost and comply with strict regulations such as USP 797/825. SWE helps reinforce the Biodex commitment to streamline, facilitate and expand the use of theranostics and other radionuclide therapies, having a direct impact on patient outcome as stated earlier this year.

"Biodex is extremely excited to bring its leadership and ambassador role in the nuclear medicine market space to this solid partnership. SWE team's Engineering, Industry, Radiopharmacy, Technical and Clinical background is truly impressive and allows Biodex to offer complementary solutions to a broad number of customers, dealers and distributors from radiopharmacies, pharma industry, cyclotron facilities to clinical and research settings," explains Frank Hebert, Global Vice President of Sales at Biodex.

"SWE is proud to be establishing this strategic partnership with such a renowned group. We are confident that our pioneering products and technology will benefit from the expertise and visibility of the Biodex brand. Together, Biodex and SWE will enhance safe access to unique technologies, which will help Nuclear Medicine specialists dispense and administer high quality care," mentions Robert Kamen, Co-founding President at SWE.

To learn more about Biodex and SWE strategic partnership and products, visit us at the 2019 EANM Annual Congress in Barcelona, Spain, October 12-16, Booth #122.

About Biodex Medical Systems, Inc.

Biodex Medical Systems, Inc. manufactures and distributes medical devices for physical medicine, nuclear medicine, molecular and medical imaging. The Biodex commitment to innovative excellence spans more than 60 years. Their customer-driven support is why leading medical facilities in 89 countries around the globe call Biodex first. THERANOSTICS. We're Ready. Are You?

About South West Exposures

South West Exposures is a unique Canadian designer and fabricator of shielding solutions, dedicated to enhancing the handling and distribution of SPECT, PET and theranostics isotopes, improving efficiency and protection to the healthcare practitioner. SWE patent pending, disruptive and customizable designs optimize the safe transportation and administration of various theranostics agents, including high energy isotopes.

For the original version on PRWeb visit: https://www.prweb.com/releases/biodex_and_south_west_exposures_announce_strategic_partnership_expanding_innovation_with_global_outreach_in_theranostics_and_nuclear_medicine/prweb16643843.htm

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com